21843-82-3 (4-chlorophenyl)mercury - acetic acid (1:1)
218438-27-8 3-Thiophenecarboxamide,2-(acetylamino)-4,5-dimethyl-N-(2-methylphenyl)-
218440-18-7 2-Piperidinecarboxylicacid, 3-ethenylidene-, methyl ester, (2R)-
218441-48-6 3-PENTANONE,2,4-DIHYDROXY-
218441-99-7 HUMAN BRAIN-DERIVED NEUROTROPHIC FACTOR
21844-32-6 {(2-BROMOETHYL)BENZYL}TRIPHENYLPHOSPHONIUM BROMIDE
218447-24-6 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-(acetylamino)-3-(chloromethyl)-8-oxo-, (4-methoxyphenyl)methylester, (6R,7R)-
218449-92-4 2-Oxazolidinone,5-(3,4-difluorophenyl)-5-methyl-
218451-68-4 Reaktionsprodukt aus Fettsureglycerid und Polyolen
21845-23-8 1-Hexanamine, N,N-dihexyl-, hydrobromide
218456-06-5 N4-(2-BROMOETHYL)-3-(2,6-DICHLOROPHENYL)-5-METHYLISOXAZOLE-4-CARBOXAMIDE
218459-99-5 Benzene, 1-methoxy-4-[(1R)-1-methyl-2-phenylethyl]-
21846-27-5 1-(9-methyl-2-nitro-9H-fluoren-9-yl)ethanone
21847-06-3 GeH4 S
2184-77-2 N-ACETYLZECTRAN
21848-62-4 (+)-N-Norglaucine
Contacter Mrs.Camila Email Us
Mobile +86 18136843696
Tel +86 25 5874 5998
QQ 3461339351
WeChat +86 18136843696
Skype live:.cid.6d3c4ae5f7de0a26
Social Media
Serving Advanced Chemicals to Global Customers
© 2009 - 2025 USCKS | King-Pharm Ver 3.0